Related to Omeros Gets $25M to Purchase Patobios’ GPCR Technology

• Rhenovia and USC to Collect $2.3M Grant to Study Brain Functions and Disorders
  
• Crucell and PATH Malaria Vaccine Program Get Funding to Develop a Prime-Boost Adenoviral Vaccine
  
• Apogenix Obtains Roughly $3.66M to Further Cancer and Inflammatory Disease Initiatives
  
• Neurotez Scores $2.73M to Progress Preclinical Leptin Therapy for Alzheimer’s Disease
  
• Grant to Pluristem Increased by $0.4M to Advance Cell Therapy for Critical Limb Ischemia
  
• Ichor and Partners Awarded $3.3M Grant to Develop Alzheimer’s Vaccine
  
• Thermo Fisher Scientific Sets Up RNAi Discovery Grant Program
  
• Crucell Wins $40.7M NIAID Contract to Develop Human Flu mAbs
  
• $1.3 Flemish Government Grant to Support Clinical Trials of ActoGeniX’ Oral Mucositis Therapy
  
• French Government Awards TcL Roughly $3.15M for Research on CD28 Antagonists in Transplant Therapy
  
• GenVec Obtains $2.5M to Enhance Vector Production Technology
  
• U.K. Government Gives Regenerative Medicine a £1.5M Boost
  
• NIH Grants $2.87M for Development of Treatment for C. difficile and Shigella Gastrointestinal Infections
  
• Revotar Wins Roughly $3.65M to Progress Selectin Antagonists Against Respiratory Conditions
  
• Einstein Obtains $3.5M to Study Epigenomics of Abnormal Fetal Growth and Chronic Kidney Disease
  
• Antigen Discovery Scores $1.8M from NIAID to Develop Chlamydia Vaccine
  
• Case Western Receives $4.9M NIH Award to Investigate Inbred Genetic Susceptibility to Colon Cancer Metastasis
  
• Boston University Obtains Five-Year $2.5M Grant to Study Cells’ Reaction to Physical Force
  
• Altor Scores $3M NCI Grant for Clinical Development of IL-2 Boosting Drug
  
• FASgen Obtains $1.4M NIH Grant to Further Preclinical Obesity Pipeline